GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (TSE:2395) » Definitions » 3-Year Revenue Growth Rate

Shin Nippon Biomedical Laboratories (TSE:2395) 3-Year Revenue Growth Rate : 20.50% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories 3-Year Revenue Growth Rate?

Shin Nippon Biomedical Laboratories's Revenue per Share for the three months ended in Dec. 2023 was 円146.54.

During the past 12 months, Shin Nippon Biomedical Laboratories's average Revenue per Share Growth Rate was 5.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 20.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 13.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Shin Nippon Biomedical Laboratories was 20.50% per year. The lowest was -9.80% per year. And the median was -3.10% per year.


Competitive Comparison of Shin Nippon Biomedical Laboratories's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's 3-Year Revenue Growth Rate falls into.



Shin Nippon Biomedical Laboratories 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Shin Nippon Biomedical Laboratories  (TSE:2395) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Shin Nippon Biomedical Laboratories 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shin Nippon Biomedical Laboratories (TSE:2395) Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (TSE:2395) Headlines

No Headlines